These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2948665)

  • 21. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH; Freed JH; Cohen PL
    J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of a T suppressor factor by using a monoclonal antibody.
    Ferguson TA; Beaman KD; Iverson GM
    J Immunol; 1985 May; 134(5):3163-71. PubMed ID: 2580016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice.
    Theofilopoulos AN; Balderas RS; Shawler DL; Lee S; Dixon FJ
    J Exp Med; 1981 Jun; 153(6):1405-14. PubMed ID: 6972998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of Ly-1 B cells in the effector phase of IgG suppression mediated by suppressor T cell factor.
    Ono K; Kato F; Taniguchi M
    J Mol Cell Immunol; 1987; 3(3):167-75. PubMed ID: 2978242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice.
    Dang-Vu AP; Pisetsky DS; Weinberg JB
    J Immunol; 1987 Mar; 138(6):1757-61. PubMed ID: 3102599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning of B cells from autoimmune MRL-lpr/lpr and MRL.xid mice.
    Pisetsky DS; Caster SA; Piper M; Scott DW; Steinberg AD
    Cell Immunol; 1984 Mar; 84(1):32-40. PubMed ID: 6607779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloned suppressor T cells derived from mice tolerized with conjugates of antigen and monomethoxypolyethylene glycol. Relationship between monoclonal T suppressor factor and the T cell receptor.
    Takata M; Maiti PK; Kubo RT; Chen YH; Holford-Strevens V; Rector ES; Sehon AH
    J Immunol; 1990 Nov; 145(9):2846-53. PubMed ID: 2145364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoreactive T cells with atypical MHC restriction from MRL-lpr/lpr mice: forbidden clones revisited.
    Naparstek Y; Baur K; Reis MD; Breitman L; Mak TW; Schwartz RS; Madaio MP
    J Mol Cell Immunol; 1988; 4(1):35-43. PubMed ID: 2471535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr mice.
    Shirai A; Aoki I; Otani M; Mond JJ; Klinman DM
    J Immunol; 1994 Aug; 153(4):1889-94. PubMed ID: 7519219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA
    J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.
    Christianson GJ; Blankenburg RL; Duffy TM; Panka D; Roths JB; Marshak-Rothstein A; Roopenian DC
    J Immunol; 1996 Jun; 156(12):4932-9. PubMed ID: 8648144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A soluble T cell suppressor factor for the mixed leukocyte response (MLR-TsF).
    Beckwith M; Arhelger C; Rich S
    Methods Enzymol; 1985; 116():416-27. PubMed ID: 2935709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.